1,062 material Form 8-K filings that 827 companies we cover made with the SEC in May 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Allegiant Travel reported first-quarter 2025 revenue of $699.1 million, up 6.5% from a year earlier, and GAAP diluted earnings of $1.73 per share versus a loss of $0.07 per share in the prior-year quarter. The company withdrew its full-year 2025 guidance, citing difficulty predicting near-term demand amid economic uncertainty, and said Tyler Hollingsworth became chief operating officer effective May 1, 2025.
Q1 2025 total operating revenue $699.1 million, up 6.5% year over year; GAAP diluted EPS $1.73 vs. loss of $0.07 a year earlier
Adjusted diluted EPS $1.81 vs. $0.57 in Q1 2024
Full-year 2025 guidance withdrawn; Q2 2025 adjusted airline-only EPS guidance of $0.50 to $1.50 remains in the filing
Tyler Hollingsworth designated chief operating officer as of May 1, 2025; he had served as interim COO since March 2025
Sunstone Hotel Investors reported first-quarter 2025 net income of $5.3 million, down from $13.0 million a year earlier, while Adjusted FFO per diluted share rose 16.7% to $0.21. The company lowered its full-year 2025 outlook, with net income now expected at $33 million to $58 million, down from $46 million to $71 million, citing recent volatility in operating trends. Shareholders also elected eight directors at the May 1, 2025 annual meeting.
Net income was $5.3 million in Q1 2025 versus $13.0 million in Q1 2024; income per diluted share was $0.01 versus $0.05.
Adjusted FFO attributable to common stockholders per diluted share rose 16.7% to $0.21; total portfolio RevPAR rose 2.2% to $221.63.
2025 net income guidance was cut to $33 million to $58 million from $46 million to $71 million.
2025 Adjusted FFO per diluted share guidance was lowered to $0.82 to $0.94 from $0.86 to $0.98.
AdaptHealth reported first-quarter 2025 net revenue of $777.9 million, down 1.8% from a year earlier, and a net loss attributable to the company of $7.2 million, compared with a $2.1 million loss in the prior-year quarter. Adjusted EBITDA fell 19.3% to $127.9 million. The company also lowered its fiscal 2025 net revenue and adjusted EBITDA guidance to account for the disposition of certain incontinence assets, reducing its outlook for shareholders.
Net revenue was $777.9 million, down from $792.5 million in the first quarter of 2024, a decrease of 1.8%.
Net loss attributable to AdaptHealth Corp. was $7.2 million, compared with a net loss of $2.1 million a year earlier.
Fiscal 2025 net revenue guidance was lowered to $3.18 billion to $3.32 billion from $3.22 billion to $3.36 billion; adjusted EBITDA guidance was lowered to $665 million to $705 million from $670 million to $710 million.
Free cash flow guidance of $180 million to $220 million was unchanged; first-quarter cash flow from operations was $95.5 million.
ADM reported first quarter 2025 diluted EPS of $0.61, down 57% from the prior year quarter, and adjusted EPS of $0.70, down 52%. The company reaffirmed its 2025 adjusted EPS guidance of $4.00 to $4.75 but said it now expects results at the lower end of that range.
Net earnings attributable to ADM were $295 million, versus $729 million a year earlier; adjusted net earnings were $338 million.
Total segment operating profit was $747 million, down 38%; Ag Services and Oilseeds profit fell 52% to $412 million.
Cash flows used in operating activities were $(342) million in the quarter, versus cash provided of $700 million a year earlier.
2025 adjusted EPS guidance of $4.00 to $4.75 was affirmed, with results now expected at the lower end of the range.
Omnicell reported first-quarter 2025 total revenue of $270 million, up 10% from a year earlier, and a GAAP net loss of $7 million, narrower than the $16 million loss a year earlier. The company lowered its full-year 2025 non-GAAP EBITDA and non-GAAP earnings per share guidance, citing higher potential supply chain costs tied to tariffs, which matters to shareholders because the profit outlook is now lower.
Q1 2025 total revenue was $270 million, up $24 million or 10% year over year, and above previously issued Q1 guidance.
Q1 2025 non-GAAP net income was $12 million, or $0.26 per diluted share, compared with $1 million, or $0.03, a year earlier.
Full-year 2025 non-GAAP EBITDA guidance is now $100 million to $145 million, and non-GAAP EPS guidance is $1.00 to $1.65, both reduced.
Q1 2025 cash flow from operations was $26 million, compared with $50 million in Q1 2024.
Waters reported first-quarter 2025 sales of $662 million, up 4% as reported and 7% in constant currency, and GAAP diluted EPS of $2.03 versus $1.72 a year earlier. The company raised its full-year 2025 non-GAAP EPS guidance to $12.75 to $13.05 and its constant currency sales growth guidance to 5.0% to 7.0%, which matters to shareholders because it signals higher expected earnings for the year.
Q1 2025 sales were $662 million, compared with $637 million in Q1 2024.
GAAP diluted EPS was $2.03 versus $1.72; non-GAAP EPS was $2.25, up 2% from $2.21.
Full-year 2025 non-GAAP EPS guidance raised to $12.75 to $13.05; reported sales growth guidance raised to 4.0% to 6.0%.
Second-quarter 2025 non-GAAP EPS is expected at $2.88 to $2.98.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.